More PRNewswire
View Older Stories View Newer Stories-
2024 BrandSpark Most Trusted Awards Winners Announced for Consumer Products, Retail and Services Brands in the 11th Annual Edition
-
TÜV Rheinland Issues "Perceptual Color Volume" Certification to Lenovo™'s New Yoga™ Pro 9i Laptop
-
WEISS TECHNIK NORTH AMERICA LAUNCHES NEW ENDURANCE SERIES CHAMBER
-
BizEquity Celebrates a Year of Enhancements and Heralds Innovative Features to Come with Launch of New Website
-
JERSEY MIKE'S PLANS MAJOR EXPANSION IN CANADA WITH REDBERRY RESTAURANTS
-
NEVADA KING INTERSECTS HIGH-GRADE OXIDE GOLD 600M NORTH OF THE ATLANTA PIT WITH 9.72 G/T AU OVER 9.1M WITHIN 47.3M OF 2.57 G/T AU, DOUBLES SIZE OF THE "NORTH EXTENSION TARGET"
-
ACAMS Appoints Neil Sternthal as Chief Executive Officer
-
Ava Community Energy Appoints Annie Henderson to Chief Customer Officer
-
Animal Dermatology Group Acquires Golden Gate Veterinary Specialists
-
FIVE-YEAR SURVIVAL RATE FOR PANCREATIC CANCER INCREASED TO 13% SIGNALING MORE PROGRESS AND MORE HOPE FOR PATIENTS
-
Natural Grocers® Invites Gunnison, CO Community to Grand Opening Celebration on January 31, 2024
-
TDK Ventures invests in pioneering e-fuel company INERATEC
-
Brennan Acquires 263,000 SF Surplus Industrial Building in Cincinnati
-
Matt Timberlake To Lead Applied Felts Inc. As President After Vortex Companies Acquisition
-
Tacoma plumbing experts advise area residents to prep for potential winter flooding
-
Everest Group Recognizes ODAIA for Market Impact, Vision, and Capability
-
Cowboy Clean Fuels Announces Significant Funding Award to Support Commercialization of Technology and Build Out of Initial Project in Wyoming
-
Veeva Completes Study Migrations to Veeva Vault EDC for Top Biopharma
-
Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
-
MahiMarkets introduces its latest product, MFXTradeHaven
-
Cellply launches its end-to-end single cell potency characterization platform VivaCyte
-
Lithia & Driveway (LAD) Schedules Release of Fourth Quarter 2023 Results
-
RADCOM to Report Fourth Quarter and Full Year 2023 Results on January 31, 2024
-
Graphite One Announces Termination of Memorandum of Understanding with Lithium-Ion Battery Anode Producer
-
Rene Sauerteig Joins Cathay Capital as Operating Partner and Board Member of Parkview Dental Partners
-
Cardumen Capital raises $120 Million consolidating its position as one of Israel's most active early-stage Deep Tech investors
-
TuSimple Announces Intention to Delist from Nasdaq
-
Garmin Ltd. schedules fourth quarter 2023 earnings call
-
AerCap Holdings N.V. to Release Fourth Quarter 2023 Financial Results on February 23, 2024
-
Summit Materials Announces Board of Directors Appointments
-
CELLIPONT BIOSERVICES SELECTS L7 INFORMATICS FOR ITS FLEXIBLE AND UNIFIED PLATFORM, ENABLING END-TO-END MANUFACTURING
-
Supervisory Council Meeting of the Lowcountry Graduate Center
-
Main Street Announces Preliminary Estimate of Fourth Quarter 2023 Operating Results
-
Maxwell Healthcare Associates and KATANA Safety Announce Partnership to Help Protect Home Health Workers
-
Unleashing Intelligent Testing: PractiTest's Smart Fox AI Assistant and Test Value Score Redefine QA Excellence
-
SodaStream® Unveils Game-Changing Partnership, Introducing MTN DEW® to its Growing Flavor Portfolio
-
USDA Agrees Clinical Trial Data for the ELIAS Cancer Immunotherapy (ECI®) Demonstrates Reasonable Expectation of Efficacy for the Treatment of Bone Cancer in Dogs
-
Exero Medical's Pivotal Clinical Study of xBar Approved by WCG in the US
-
THE N2 COMPANY CELEBRATES 20 YEARS OF PROVING PRINT MEDIA NAYSAYERS WRONG
-
CAR T Global Consultant Inc. Announces the launch of the first ever Full Service Contract Commercialization Organization specifically designed for Cell & Gene Therapy (CGT CCO)
-
Vortex Metal's Recap of 2023 Milestones and Outline of 2024 Catalysts
-
enCore Energy Provides Update on South Texas Uranium Operations
-
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
-
PharmaCann Kicks Off Adult Use Retail and Wholesale in New York
-
R.J. O'Brien Appoints Patrick Christie to Lead Hrvyst Ag Tech Business Unit
-
A Winning Quarter Back: ALDI Offers 25% Off Game Day Must-Haves
-
Bolster Hires Two Executives from Proofpoint and vArmour to Accelerate A.I. Innovation in Phishing Detection and Response
-
Department of Defense's Michael Miller to Keynote Spring 2024 Employing U.S. Vets Conference
-
VIVREAU WATER PARTNERS WITH 4OCEAN IN "BUY ONE, PULL ONE" INITIATIVE
-
GLOBAL PET AND FIBERS MANUFACTURER LATEST ADDITION TO INNOVAPPTIVE'S GROWING CLIENT LIST
